strong year ep advanc
ci post strong ep growth full year come
manag offer ep guidanc
releas final ci reiter multi-year target hit ep
ci confid achiev synergi target mln four year esrx
acquisit complet late compani remain track year synergi
see step function year built number achiev slightli beat
first year synergi goal realiz mln admin expens reduct
earn growth health servic divis reflect solid underli core
growth benefit increas y/i administr expens synergi
sg ratio expect higher y/i increas reflect impact
start-up cost associ ci new collabor prime well
residu administr expens associ support transit client
margin seen similar ci indic margin
slightli pre-tax target ci expect margin similar
uptick new member low first year margin continu invest present
short term headwind profit gain ci pleas
membership growth alreadi achiev larg portion gain
come market enrol increas versu new market product
group life disabl sale expect close ci sale group life
disabl busi expect ep neutral result ci abl
deploy result proce either debt repay share repurchas cigna
remain commit de-lever balanc sheet upper rang debt capit
ratio end ci bln share repurchas author
updat tp roll forward tp multipl updat tp
base vs prev ep estimate tp assum ci share trade in-
line current group averag roughli current risk includ esrx
valuat metric
number share
 close
legal entiti disclosur statu non-u analyst us disclosur credit suiss seek busi
compani cover research report result investor awar firm may conflict interest could
affect object report investor consid report singl factor make invest decis
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
total debt capit
price
headquart bloomfield ct global health servic
medic intern market group disabl
blue sky valuat asum ci trade ep
grey sky valuat assum ci face oper challeng
core busi esrx pbm busi scenario
see ci share trade ep estim
 close
highlight manag
post quarterli confer call discuss ci manag review result
expect segment membership trend text list
question compani respons answer verbatim put
compani answer proper context give-and-tak format
question think apples-to-appl earn growth
divis previous talk expect mid-to-
high singl digit growth synergi benefit
answer releas said expect show mid-to-high singl digit
percentag earn growth divis growth littl
would like mid-singl digit type trend
compani saw apples-to-appl basi synergi benefit top
question look improv rel benefit
number suppli chain initi begun take full effect strong
perform specialti pharmaci includ full run rate specialti gener
introduc earli realiz synergi partial off-set strand
overhead cost associ earli termin contract
play expect
answer item highlight play expect ci saw continu benefit
suppli chain initi take effect favor full run rate
specialti gener call also saw continu realiz synergi
question saw strong earn growth busi
mln vs first three quarter year
drove increas
answer ci achiev continu good perform across intern busi segment
beyond normal trend littl favor benefit expens side term
benefit expens ratio also good favor sg side oper
expens effici noth uniqu littl bit easier
comp increas invest spend littl higher benefit expens
ratio ci pleas perform grow effect
currency-adjust basi see good momentum divis head next year
question talk remov pyd favor tax item
time impact resumpt hif
perman suspens look like mayb come
intra-year renew impact exclud item forecast
earn growth compani see
answer correct right way think
question consid cadenc earn throughout year
think first half earn contribut less contribut
first half last year given fast-grow segment second
answer ci expect earn earn ci
expect lower ep contribut normal trajectori health servic earn
also impli contribut greater contribut greater addit
leap year also extra day claim
question think pace synergi still
track greater mln synergi target
answer ci feel good progress compani made respect
synergi target compani remain track year target see step function
amount expect achiev year built guidanc overal track
greater mln synergi target
ci initi estim mln admin expens synergi year
compani met slightli exceed number realiz ci feel good
abil deliv state synergi target next sever year
question thought relat strand cost headwind plu
would expect prime set cost overcom get
mid-singl digit growth pbm easi comp core core
growth pbm high singl digit normal
answer ci expect mid-singl digit earn growth health servic y/i
reflect solid underli growth benefit increas y/i administr expens
synergi sg ratio expect higher y/i reflect
impact client transit ci discuss start-up cost associ ci
collabor prime well residu administr expens associ
support transit client recal similar strand cost
expect highest declin throughout
question medic cost trend outlook
could discuss need happen reach compani long-term
object reduc medic cost trend growth cpi roughli
answer ci pleas deliv industry-lead medic trend seventh
consecut year row step attract trend compani
believ track deliv cpi-level long-term goal
compani alreadi see lt target cost trend engag penetr
longer-held client relationship today ci need continu innov evolv get
better engag customer/cli side well physician side
also consider work site care type activ
drive better cost ci also look better leverag digital/technolog continu leverag
capabl esrx afford compani term pharmaceut save particular
specialti pharmaci thing drive compani toward cpi-level trend
futur physician side financi risk-shar compon continu deepen
expand value-bas care relationship also import ci collabor
account care relationship today look continu expand beyond pcp
specialist hospit system etc
question point integr medic earn grow
bln baselin report earn bln impli
growth explain roughli mln adjust made get
baselin
answer two thing call mln pre-tax assumpt recurr
favor pyd mln pre-tax time impact hif return ultim repeal
back-end piec relat hif figur bit price
dynam associ hif elimin put pressur
question talk individu margin normal expect
busi perform look like compani expect
membership declin y/i compani think
individu market public exchang long-term
answer ci pleas perform individu busi taken
measur approach number year continu modestli grow compani
presenc space look three-year trajectori saw strong result
margin ci expect saw step-down still north ci target
step ci see continu good perform probabl within toward higher
end pre-tax target margin ci expand three addit market
within ci market compani want make sure maintain good price disciplin given
new entrant etc overal ci like compani presenc individu market would
bia continu growth time
question speak medicar advantag margin expect
look like ci expect consolid neg impact y/i bp due
live mix normal hix margin
answer think slightli target margin probabl
similar place think new live come board continu invest
also revenu leverag come bring new live ci excit
custom growth seen far growth larg come
exist plan manag believ opportun grow enrol
geograph introduct new product
question guid health servic incom op bln
growth recal properli strand cost neither headwind tailwind
go annual basi mean
mln strand cost therefor natur
roughli lift earn lift ep
answer ci point mln strand overhead relat transit
client like diminish howev sequenti quarterli progress
mirror imag trend highest level expens
recogn strand overhead remov three way
continu enterpris valu initi program esrx put place pre-acquisit
continu organ growth absorpt strand overhead due
insourc script optum organ growth exampl prime therapeut
collabor step strand overhead go forward
therefor reason think cent lift issu els
question begin grow medicar advantag busi
share thought advanc notic around esrd popul
elig much see year come
market expans and/or new product ppo offer etc versu market
growth previous exist product
answer formal comment advanc notic note call
industri averag chang outlin advanc identifi consist
book term esrd popul ci expect ultim smaller impact
compani aggreg franchis continu evalu esrd postur
evolv ci approach esrd opportun msa-by-msa benefit offering-by-
benefit offer basi necessari tool capabl manag esrd
popul ci see growth come exist product exist geographi
vs new geographi new product
question see much impact quarter elev flu season
answer certainli flu season somewhat elev rel year ago
signific impact ci call
question coronaviru focu around world particularli asia
oper compani see impact
coronaviru look sar swine flu give us guidanc
might impact busi
answer ci monitor situat busi near term probabl
offset impact ci would expect disrupt new product sale
particularli china time lower level util today
gener popul china gener avoid public place like hospit healthcar
facil end day ci see materi impact either
market enterpris whole way background ci exposur china
jv structur compani share china busi overal
signific materi today rel financi perform entir compani
question mention call litig expect
resolv month ci feel strongli compani collect break
fee could remind us potenti award amount expect
provid context around ci level confid collect break
fee would factor operations/delev potenti
litig appeal follow month decis
answer ci said compani expect resolut end month
deadlin chanceri court ci specul potenti appeal
decis appeal delawar suprem court
question regard oscar partnership ci current expect
membership growth near- long-term membership
growth partnership includ outlook
answer ci excit partnership oscar see anoth exampl ci
undisput partner choic healthcar ecosystem partnership anoth
way ci work anoth innov partner drive valu marketplac
custom client four market dont launch much later year ci expect
meaning impact membership growth see opportun
growth longer term
question gave estim script growth expect see prime
relationship agreement roll april compani also mention
up-front invest requir end day contract posit
neg bottom line year sens potenti bottom line impact
answer ci excit work togeth prime compani believ go
abl improv afford mln live demonstr strength ci
capabl health servic busi also compani commit greater
level afford term benefit see neutral due partial-
year start date ventur begin also start-up cost associ roll new
ventur start-up cost laps ci full year script partnership
meaning contributor
question discuss confer call acceler
buy-back off-set impact lose contribut disabl life
busi compani said expect transact net neutral ep
predic acceler buy-back aspect deal
might off-set lost earn subsidiari favor long-term
contract sell unit disabl life product go forward
receiv fee
answer ci pleas result group life disabl busi driven mani
year pleas agreement new york life gener net
bln tax proce transact ep neutral come
result ci abl deploy result proce either debt repay share
repurchas compani continu commit de-lever balanc sheet
upper end ci also bln outstand share repurchas
author consid two marker guid kind rate ci deploy
capit come closer sale date
question could potenti continu sell product custom
base presum go situat get fee commiss
answer ci on-going agreement new york life go place upon sale
howev econom contribut sell product post sale match
earn busi gener full own
question anyth els ci would like highlight
answer ci strong year execut effect deliv promis
expect continu
okay great thank
compani mention price
 rice certifi view express report accur reflect person view subject compani
secur part compens directli indirectli relat specif recommend view express
report
